Production of Galacto‐Oligosaccharides by Enzymatic Membrane Reactors Using Free β ‐Galactosidase
Chemie Ingenieur Technik · 2024-04 · 96 (4) · 389-400
DOI: 10.1002/cite.202300218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemie Ingenieur Technik, online erschienen am 11.03.2024. Verfasst von Cao Teng und 3 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Prebiotic galacto‐oligosaccharides (GOSs) are synthesized by transgalactosylation of lactose using β ‐galactosidases. Well‐established, large‐scale production of GOS is performed by stirred‐tank reactors (STR) operating in batch fashion. Main manufacturing expenses are attributed to enzyme purchase costs and the downstream operations required for subsequent enzyme inactivation and removal. In the last decades, several studies and patents have appeared on free enzyme membrane reactor (FEMR) as an economic alternative to STR due to enhanced enzyme recovery and reuse. In this review, we attempt to summarize the key design aspects, the catalytic performance and efficiency of FEMR compared to STR technology, and the main concerns related to stable product quality over long‐term operation.
Zitieren
APA
Teng, C., Nath, A., Galambos, I., & Kovács, Z. (2024). Production of Galacto‐Oligosaccharides by Enzymatic Membrane Reactors Using Free β ‐Galactosidase. Chemie Ingenieur Technik, 96(4), 389-400. https://doi.org/10.1002/cite.202300218
Vancouver
Teng C, Nath A, Galambos I, Kovács Z. Production of Galacto‐Oligosaccharides by Enzymatic Membrane Reactors Using Free β ‐Galactosidase. Chemie Ingenieur Technik. 2024;96(4):389-400. doi:10.1002/cite.202300218
BibTeX
@article{Teng2024,
author = {Teng, Cao and Nath, Arijit and Galambos, Ildikó and Kovács, Zoltán},
title = {Production of Galacto‐Oligosaccharides by Enzymatic Membrane Reactors Using Free β ‐Galactosidase},
journal = {Chemie Ingenieur Technik},
year = {2024},
volume = {96},
number = {4},
pages = {389--400},
doi = {10.1002/cite.202300218}
}
EUVIMED